Derivative exercise or conversion — not an open-market buy.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Officer sold ~$136K of BIO shares in the open market
Traded May 11, 2026 · Filed May 13, 2026
- ~$136K
- Reported value · 550 sh @ $246.54
- 346
- Holds after · shares reported
- +55.8%
- stock since the trade · S&P 500 +4.8%, $243.79 → $379.82 on Oct 5
Why it stands out
Bio-Rad Laboratories's President, CDG sold $136K of Bio-Rad Laboratories shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- May 11, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- May 13, 2026
Officer$100K–$500K
Context
- Classification
open market sale
Code S — open-market or private sale
- Absolute commitment
~$135,597
Shares × reported transaction price
- Timing vs results
11 days after results of Apr 30, 2026, 85 days before results of Aug 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
- Planned / mechanical clue